Device Week, 20 June, 2019 – ADA 2019 Key Players,Trial Results From Kinetics And Myriad Genetics

In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about her upcoming Market Intelligence story based on interviews with the biggest players in the diabetes market at the recent annual American Diabetes Association meeting. Reed Miller discusses Global Kinetics' recent data on its Personal KinetiGraph that can help identify Parkinson's patients most likely to benefit from device-assisted therapy and Myriad Genetics' POLO trial results. Listen to the podcast via the player below: https://medtech.pharmaintelligence.informa.com/MT125248/ADA-Exec-Chat-Hiten-Chawla-Medtronics-VP-Of-Global-Marketing-Discusses-Diabetes-Business-Plans https://medtech.pharmaintelligence.informa.com/MT125209/Glooko-Inks-Partnership-Deal-With-Companion-Medical-To-Integrate-Insulin-Pen-Data https://medtech.pharmaintelligence.informa.com/MT125203/Glooko-And-T1D-Exchange-Enter-Partnership-To-Leverage-Device-Data-From-Type-1-Diabetics For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: Global Kinetics’ Personal KinetiGraph Identifies Parkinson’s Patients Suitable For Deep Brain Stimulation https://medtech.pharmaintelligence.informa.com/MT125266/Global-Kinetics-Personal-KinetiGraph-Identifies-Parkinsons-Patients-Suitable-For-Deep-Brain-Stimulat Myriad Foresees Important Role For Genetic Testing In Pancreatic Cancer, Breast Cancer, And Beyond https://medtech.pharmaintelligence.informa.com/MT125251/Myriad-Foresees-Important-Role-For-Genetic-Testing-In-Pancreatic-Cancer-Breast-Cancer-And-Beyond https://medtech.pharmaintelligence.informa.com/MT125258/Why-Unprecedented-Numbers-Are-Flocking-To-Brussels-In-Uncertain-Times https://medtech.pharmaintelligence.informa.com/MT125264/Lack-Of-Funding-Stalls-Major-US-FDA-Cybersecurity-Initiative